journal cover

Imaging Biomarkers of Alzheimer's Disease in Multiple Sclerosis

Annals of Neurology

Jan 24, 2020

Burcu ZeydanKejal Kantarci

Abstract

To investigate β-amyloid and tau depositions using Pittsburgh compound B (PiB) PET and AV1451 tau PET imaging in aging multiple sclerosis (MS) patients. Patients with MS (n=16) and controls (n=80) matched for age, sex and APOE ε4 status from the population-based Mayo Clinic Study of Agi...read more

Mentioned in this Paper

Population Group
Finding
Multiple Sclerosis
APOE Gene Product
(18F)T807 compound
Positron-Emission Tomography
Cerebral Cortex
N-methyl-(11C)2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole
Alzheimer's Disease
Amyloid beta-Peptides
11
1
Paper Details
References
  • References47
  • Citations
12345
  • References47
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.

Similar Papers Found In These Feeds

Tau Toxicity in the Synapses

Tau toxicity has been implicated in the emergence of synaptic dysfunction in Alzheimer's disease. Here is the latest research on Tau Toxicity in the Synapses.

Brain Aging

Here is the latest research on intrinsic and extrinsic factors, as well as pathways and mechanisms that underlie aging in the central nervous system.

Multiple Sclerosis: Imaging

Magnetic resonance imaging has been used to diagnose and monitor the disease progression in multiple sclerosis. MRI has improved the management of MS patients and provided information on the level of atrophy in the brain and the severity of the disease. Discover the latest research on multiple sclerosis imaging here.

Tau Toxicity in the Synapses

Tau toxicity has been implicated in the emergence of synaptic dysfunction in Alzheimer's disease. Here is the latest research on Tau Toxicity in the Synapses.

Multiple Sclerosis: Diagnostic Methods

Multiple Sclerosis (MS) is a demyelinating autoimmune disease of the CNS, resulting in symptoms including optic neuritis and motor weakness. Here is the latest research on development and application of methods for diagnosis of MS.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's Disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's Disease here.

Tauopathies

Tauopathies are neurodegenerative disorders caused due to misfolding and aggregation of the tau protein in neurofibrillary tangles in the brain. Discover the latest research on tauopathies here.

MS: Therapies

The feed focuses on therapeutic interventions used to treat Multiple Sclerosis.

Tau Aggregation: Genomics

Tau Aggregation is an important characteristic in some neurodegenerative disorders, including Alzheimer’s Disease. Discover the latest research using genomics to understand Tau Aggregation.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a chronic neurodegenerative disease. This feed focuses on the underlying role of Tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's.

Multiple Sclerosis

Multiple Sclerosis is a demyelinating autoimmune disease of the CNS, resulting in symptoms including optic neuritis and motor weakness. Discover the latest research on Multiple Sclerosis here.

Alzheimer's Disease: Abeta

Alzheimer's disease (AD) is a chronic neurodegenerative disease associated with accumulation of amyloid plaques, which are comprised of amyloid beta. Here is the latest research in this field.

Decision Making & Cognitive Aging

While abilities like vocabulary resist aging, other abilities such as memory, decision-making, and reasoning, gradually decline. Here is the latest research on decision-making and cognitive aging.

Alzheimer's Disease: Neuroimaging

Alzheimer's disease (AD) is a chronic neurodegenerative disease. Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

Related Papers

Annals of Neurology

AV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies

Annals of NeurologyNovember 20, 2016
Kejal KantarciRonald C Petersen
Annals of Neurology

Tau positron emission tomographic imaging in aging and early Alzheimer disease

Annals of NeurologyOctober 28, 2015
Keith A JohnsonReisa Sperling
© 2020 Meta ULC. All rights reserved

Imaging Biomarkers of Alzheimer's Disease in Multiple Sclerosis

Annals of Neurology

Jan 24, 2020

Burcu ZeydanKejal Kantarci

PMID: 31970802

DOI: 10.1002/ana.25684

Abstract

To investigate β-amyloid and tau depositions using Pittsburgh compound B (PiB) PET and AV1451 tau PET imaging in aging multiple sclerosis (MS) patients. Patients with MS (n=16) and controls (n=80) matched for age, sex and APOE ε4 status from the population-based Mayo Clinic Study of Agi...read more

Mentioned in this Paper

Population Group
Finding
Multiple Sclerosis
APOE Gene Product
(18F)T807 compound
Positron-Emission Tomography
Cerebral Cortex
N-methyl-(11C)2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole
Alzheimer's Disease
Amyloid beta-Peptides
11
1

Similar Papers Found In These Feeds

Tau Toxicity in the Synapses

Tau toxicity has been implicated in the emergence of synaptic dysfunction in Alzheimer's disease. Here is the latest research on Tau Toxicity in the Synapses.

Brain Aging

Here is the latest research on intrinsic and extrinsic factors, as well as pathways and mechanisms that underlie aging in the central nervous system.

Related Papers

Annals of Neurology

AV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies

Annals of NeurologyNovember 20, 2016
Kejal KantarciRonald C Petersen
Annals of Neurology

Tau positron emission tomographic imaging in aging and early Alzheimer disease

Annals of NeurologyOctober 28, 2015
Keith A JohnsonReisa Sperling
Paper Details
References
  • References47
  • Citations
12345
  • References47
  • Citations
  • quote and clock

    No citations available

    This paper may not have been cited yet.
/papers/imaging-biomarkers-of-alzheimers-disease-in/31970802